Cite
HARVARD Citation
Wagner, K. et al. (2021). Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double‐blind, placebo‐controlled, dose‐titration trial. Muscle & nerve. 64 (3), pp. 285-292. [Online].